Activation of miR-31 function in already-established metastases elicits metastatic regression.
暂无分享,去创建一个
R. Weinberg | F. Reinhardt | Scott Valastyan | Ferenc Reinhardt | Robert A Weinberg | Scott Valastyan | Nathan Benaich | Amelia Chang | Nathan Benaich | Amelia Chang | Ferenc Reinhardt
[1] B. Fingleton,et al. Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.
[2] Andrea Ventura,et al. MicroRNAs and Cancer: Short RNAs Go a Long Way , 2009, Cell.
[3] Robert A. Weinberg,et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model , 2010, Nature Biotechnology.
[4] R. Weinberg,et al. Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis. , 2009, Genes & development.
[5] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[6] Jean Jakoncic,et al. Migrastatin analogues target fascin to block tumour metastasis , 2011, Nature.
[7] P. Steeg. Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.
[8] R. Eils,et al. Systemic spread is an early step in breast cancer. , 2008, Cancer cell.
[9] S. Digumarthy,et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.
[10] L. Lim,et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.
[11] I. Fidler,et al. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.
[12] R. Weinberg,et al. miR-31: A crucial overseer of tumor metastasis and other emerging roles , 2010, Cell cycle.
[13] K. Kelnar,et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. , 2010, Cancer research.
[14] Y. Hitoshi,et al. R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. , 2010, Cancer research.
[15] T. Oskarsson,et al. Diverted total synthesis leads to the generation of promising cell-migration inhibitors for treatment of tumor metastasis: in vivo and mechanistic studies on the migrastatin core ether analog. , 2010, Journal of the American Chemical Society.
[16] J. Massagué,et al. Cancer Metastasis: Building a Framework , 2006, Cell.
[17] R. Weinberg,et al. Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis. , 2010, Cancer research.
[18] Kathryn A. O’Donnell,et al. Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model , 2009, Cell.
[19] Dan Theodorescu,et al. Learning therapeutic lessons from metastasis suppressor proteins , 2009, Nature Reviews Cancer.
[20] Yusuke Yamamoto,et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[21] F. Slack,et al. Regression of murine lung tumors by the let-7 microRNA , 2009, Oncogene.
[22] R. Weinberg,et al. MicroRNAs: Crucial multi-tasking components in the complex circuitry of tumor metastasis , 2009, Cell cycle.
[23] K. Rieger-Christ,et al. A MicroRNA expression profile defining the invasive bladder tumor phenotype. , 2011, Urologic oncology.
[24] Robert A. Weinberg,et al. A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis , 2009 .
[25] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[26] Margaret S. Ebert,et al. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.
[27] Ruud H. Brakenhoff,et al. Detection, clinical relevance and specific biological properties of disseminating tumour cells , 2008, Nature Reviews Cancer.
[28] Lewis C. Cantley,et al. AKT/PKB Signaling: Navigating Downstream , 2007, Cell.